Literature DB >> 23468055

Potential of artemisinin-based combination therapies to block malaria transmission.

Ric N Price.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23468055      PMCID： PMC4627501          DOI： 10.1093/infdis/jit079

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  12 in total

1.  Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.

Authors:  F Nosten; M van Vugt; R Price; C Luxemburger; K L Thway; A Brockman; R McGready; F ter Kuile; S Looareesuwan; N J White
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

Review 2.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Risk factors for gametocyte carriage in uncomplicated falciparum malaria.

Authors:  R Price; F Nosten; J A Simpson; C Luxemburger; L Phaipun; F ter Kuile; M van Vugt; T Chongsuphajaisiddhi; N J White
Journal:  Am J Trop Med Hyg       Date:  1999-06       Impact factor: 2.345

4.  Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.

Authors:  A Ratcliff; H Siswantoro; E Kenangalem; R Maristela; R M Wuwung; F Laihad; E P Ebsworth; N M Anstey; E Tjitra; R N Price
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

5.  Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.

Authors:  Elizabeth A Ashley; Srivicha Krudsood; Lucy Phaiphun; Siripan Srivilairit; Rose McGready; Wattana Leowattana; Robert Hutagalung; Polrat Wilairatana; Alan Brockman; Sornchai Looareesuwan; Francois Nosten; Nicholas J White
Journal:  J Infect Dis       Date:  2004-10-18       Impact factor: 5.226

6.  Effects of artemisinin derivatives on malaria transmissibility.

Authors:  R N Price; F Nosten; C Luxemburger; F O ter Kuile; L Paiphun; T Chongsuphajaisiddhi; N J White
Journal:  Lancet       Date:  1996-06-15       Impact factor: 79.321

7.  Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.

Authors:  Frank Smithuis; Moe Kyaw Kyaw; Ohn Phe; Thein Win; Pyay Phyo Aung; Aung Pyay Phyo Oo; Arkar Linn Naing; Mya Yee Nyo; Naing Zaw Htun Myint; Mallika Imwong; Elizabeth Ashley; Sue J Lee; Nicholas J White
Journal:  Lancet Infect Dis       Date:  2010-09-09       Impact factor: 25.071

8.  Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.

Authors:  Emmanuel Arinaitwe; Taylor G Sandison; Humphrey Wanzira; Abel Kakuru; Jaco Homsy; Julius Kalamya; Moses R Kamya; Neil Vora; Bryan Greenhouse; Philip J Rosenthal; Jordan Tappero; Grant Dorsey
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

9.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

Review 10.  Early parasitological response following artemisinin-containing regimens: a critical review of the literature.

Authors:  Debashish Das; Ric N Price; Delia Bethell; Philippe J Guerin; Kasia Stepniewska
Journal:  Malar J       Date:  2013-04-19       Impact factor: 2.979
View more
  6 in total

1.  Imaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against Plasmodium falciparum female gamete formation.

Authors:  Celia Miguel-Blanco; Joël Lelièvre; Michael J Delves; Ana I Bardera; Jesús L Presa; María José López-Barragán; Andrea Ruecker; Sara Marques; Robert E Sinden; Esperanza Herreros
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

2.  Artemisone and Artemiside Are Potent Panreactive Antimalarial Agents That Also Synergize Redox Imbalance in Plasmodium falciparum Transmissible Gametocyte Stages.

Authors:  Dina Coertzen; Janette Reader; Mariëtte van der Watt; Sindisiwe H Nondaba; Liezl Gibhard; Lubbe Wiesner; Peter Smith; Sarah D'Alessandro; Donatella Taramelli; Ho Ning Wong; Jan L du Preez; Ronald Wai Keung Wu; Lyn-Marie Birkholtz; Richard K Haynes
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

3.  Identification of inhibitors of Plasmodium falciparum gametocyte development.

Authors:  Sandra Duffy; Vicky M Avery
Journal:  Malar J       Date:  2013-11-11       Impact factor: 2.979

Review 4.  Does the Use of Dihydroartemisinin-Piperaquine in Treating Patients with Uncomplicated falciparum Malaria Reduce the Risk for Recurrent New falciparum Infection More Than Artemether-Lumefantrine?

Authors:  Wisdom Akpaloo; Edward Purssell
Journal:  Malar Res Treat       Date:  2014-06-19

Review 5.  Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data.

Authors:  Prabin Dahal; Umberto d'Alessandro; Grant Dorsey; Philippe J Guerin; Christian Nsanzabana; Ric N Price; Carol H Sibley; Kasia Stepniewska; Ambrose O Talisuna
Journal:  BMC Med       Date:  2015-09-07       Impact factor: 8.775

6.  Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo.

Authors:  M A Onyamboko; C I Fanello; K Wongsaen; J Tarning; P Y Cheah; K A Tshefu; A M Dondorp; F Nosten; N J White; N P J Day
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.